Diagnostic Criteria for Viral Pneumonia

Clinical Assessment

The American Thoracic Society recommends that viral pneumonia diagnosis should consider clinical features such as fever, dry cough, and shortness of breath, often with a subacute onset compared to bacterial pneumonia 1

Hematology examination is crucial in diagnosing viral pneumonia, with the Infectious Diseases Society of America noting that it typically shows normal or decreased white blood cell count, decreased lymphocyte count, normal or increased monocytes, and potentially decreased CD4 and CD8 T cell counts 1, 2, 3
Inflammatory markers such as elevated C-reactive protein and erythrocyte sedimentation rate, with procalcitonin usually normal or only mildly elevated, are observed in viral pneumonia, according to the American College of Chest Physicians 1, 4

The Centers for Disease Control and Prevention recommend respiratory virus nucleic acid detection as the gold standard for viral identification, which can detect common respiratory viruses including influenza, parainfluenza, adenovirus, respiratory syncytial virus, rhinovirus, and human metapneumovirus 1, 3, 4
Rapid antigen testing provides quick screening for specific viruses like influenza A, B, and H7N-subtypes, but has relatively high false-negative rates, as noted by the World Health Organization 1, 3

Chest CT findings in viral pneumonia include patchy ground-glass opacities, interlobular septal thickening, and airway-centric distribution, according to the Fleischner Society 1, 5
Imaging progression stages of viral pneumonia include ultra-early, early, rapid progression, consolidation, and dissipation stages, as described by the Radiological Society of North America 1, 2, 4, 6

Viral pneumonia must be distinguished from other viral pneumonias, atypical pneumonias, bacterial pneumonia, and non-infectious conditions, as recommended by the American College of Physicians 1

Diagnosis should be based on clinical gestalt, chest imaging, laboratory findings, and specific viral pathogen identification through nucleic acid detection, according to the European Respiratory Society 1, 3
Severity assessment should consider clinical scores, patient's socioeconomic status, and recognition of viral and bacterial co-infections, as noted by the International Society for Influenza and other Respiratory Virus Diseases 3